ABBV  valuation analysis

Basics
Name: AbbVie Inc
Description: AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 03, 2021
Market cap: $187.10B (37th)
Sales(TTM): $45.80B (57th)
Earnings(TTM): $4.62B (54th)

Value
FFER: 0.96 (why)
Actual price: $106.00
FFEThis is AbbVie Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $109.36
Quantile: ABBV is priced correctly given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
AbbVie Inc
"Drug Manufacturers-General" industry
Sales / MarketCap
AbbVie Inc
"Drug Manufacturers-General" industry
Book / MarketCap
AbbVie Inc
"Drug Manufacturers-General" industry
Equity / Assets
AbbVie Inc
"Drug Manufacturers-General" industry